GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Cash And Cash Equivalents

DocGo (DCGO) Cash And Cash Equivalents : $89.5 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DocGo Cash And Cash Equivalents?

DocGo's quarterly cash and cash equivalents increased from Mar. 2024 ($41.24 Mil) to Jun. 2024 ($66.06 Mil) and increased from Jun. 2024 ($66.06 Mil) to Sep. 2024 ($89.46 Mil).

DocGo's annual cash and cash equivalents declined from Dec. 2021 ($175.54 Mil) to Dec. 2022 ($157.34 Mil) and declined from Dec. 2022 ($157.34 Mil) to Dec. 2023 ($59.29 Mil).


DocGo Cash And Cash Equivalents Historical Data

The historical data trend for DocGo's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Cash And Cash Equivalents Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
47.74 32.42 175.54 157.34 59.29

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.92 59.29 41.24 66.06 89.46

DocGo Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


DocGo  (NAS:DCGO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


DocGo Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of DocGo's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


DocGo Business Description

Traded in Other Exchanges
N/A
Address
35 West 35th Street, Floor 6, New York, NY, USA, 10001
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
Executives
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405